pLEX307-SARS-CoV-2-3CL-C145A
(Plasmid
#160279)
-
PurposeAllows for constituitive mammalian expression of the SARS-CoV-2 3CL protease with C145A mutation via transfection or lentivirus
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | ||
---|---|---|---|---|---|---|
Plasmid | 160279 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $75 |
This material is available to academics and nonprofits only.
Backbone
-
Vector backbonepLEX_307
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable ; NEB 10Beta
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name3CL Protease
-
SpeciesSARS-CoV-2
-
Insert Size (bp)924
-
MutationC145A
- Promoter EF1a
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer Unknown (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Terms and Licenses
-
Industry Terms
- Not Available to Industry
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLEX307-SARS-CoV-2-3CL-C145A was a gift from Alejandro Chavez (Addgene plasmid # 160279 ; http://n2t.net/addgene:160279 ; RRID:Addgene_160279) -
For your References section:
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors. Resnick SJ, Iketani S, Hong SJ, Zask A, Liu H, Kim S, Melore S, Nair MS, Huang Y, Tay NES, Rovis T, Yang HW, Stockwell BR, Ho DD, Chavez A. bioRxiv. 2020 Aug 29. doi: 10.1101/2020.08.29.272864. 10.1101/2020.08.29.272864 PubMed 32869020